Effects of platelet-activating factor on arteriolar and venular tone in rat trachea

Microvascular Research

Volumn 53, Issue 1, 1997, Pages 63-72

  Collins, Lynell C ^a   Roberts, Andrew M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GINKGOLIDE B; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; BLOOD VESSEL TONE; BRONCHOSPASM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TOPICAL DRUG ADMINISTRATION; TRACHEA; VASOCONSTRICTION;

EID: 0030994382     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1996.1992     Document Type: Article

References (27)

1. Akopov, S. E., Sercombe, R., and Seylaz, J. (1995). Actions of platelet-activating factor on isolated rabbit basilar artery: Modulation by activated polymorphonuclear leukocytes. J. Vasc. Res. 32, 49-57.
2. Alving, K., Fornhem, C., and Lundberg, J. M. (1993). Pulmonary effects of endogenous and exogenous nitric oxide in the pig: Relation to cigarette smoke inhalation. Br. J. Pharmacol. 110, 739-746.
3. Argiolas, L., Fabi, F., and del Basso, P. (1995). Mechanisms of pulmonary vasoconstriction and bronchoconstriction produced by PAF in the guinea-pig: Role of platelets and cyclo-oxygenase metabolites. Br. J. Pharmacol. 114, 203-209.
4. Bar-Natan, M. F., Wilson, M. A., Spaine, D. A., and Garrison, R. N. (1995). Platelet-activating factor and sepsis-induced small intestinal microvascular hypoperfusion. J. Surg. Res. 58, 38-45.
5. Bellan, J. A., Minkes, R. K., Hood, J. S., McMahon, T. J., Higuera, T. R., Nossaman, D. B., McNamara, D. B., and Kadowitz, P. J. (1992). Analysis of pulmonary and systemic vascular responses to platelet-activating factor in the cat. Am. J. Physiol. 263, H234-H243.
6. Beneviniste, J., Henson, P. M., and Cochrane, C. G. (1972). Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and platelet-activating factor. J. Exp. Med. 136, 1356-1377.
7. Braquet, P., Touqui, L., Shen, T. Y., and Vargaftig, B. B. (1987). Perspectives in platelet-activating factor research. Pharmacol. Rev. 39, 97-145.
8. 2. J. Appl. Physiol. 77, 2817-2826.
9. Claing, A., Bkaily, G., Berthiaume, N., Sirois, P., Rola-Pleszczynski, M., and D'Orleans-Juste, P. (1994). Role of R-type calcium channels in the response of the perfused arterial and venous mesenteric vasculature of the rat to platelet-activating factor. Br. J. Pharmacol. 112, 1202-1208.
10. Corboz, M. R., Ballard, S. T., and Taylor, A. E. (1994). Effect of nitric oxide on tracheal microvessel diameters in rats. FASEB J. 8, A132.
11. Corfield, D. R., Webber, S. E., and Widdicombe, J. G. (1991). Mechanisms of platelet activating factor-induced changes in sheep tracheal blood flow. Br. J. Pharmacol. 103, 1740-1744.
12. Ekelund, U., and Mellander, S. (1990). Role of endothelium-derived nitric oxide in the regulation of tonus in large-bore resistant vessels, arterioles and veins in cat skeletal muscle. Acta Physiol. Scand. 140, 301-309.
13. Filep, J. G., and Földes-Filep, E. (1993). Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat. Br. J. Pharmacol. 110, 1347-1352.
14. Henderson, W. R., Jr. (1991). Eicosanoids and platelet-activating factor in allergic respiratory diseases. Am. Rev. Respir. Dis. 143, S86-S90.
15. Kamata, K., Numazawa, T., and Kasuya, Y. (1994). Decrease in vasodilator effects of platelet-activating factor in resistance vessels of spontaneously hypertensive rats. Eur. J. Pharmacol. 259, 321-323.
16. Kim, D., and Durán, W. N. (1995). Platelet-activating factor stimulates protein tyrosine kinase in hamster cheek pouch microcirculation. Am. J. Physiol. 268, (Heart Circ. Physiol. 37), H399-H403.
17. McFadden, E. R., Jr. (1992). Microvasculature and airway responses. Am. Rev. Respir. Dis. 145, S42-S43.
18. Minor, Th., Isselhard, W., and Yamaguchi, T. (1995). Involvement of platelet activating factor in microcirculatory disturbances after global hepatic ischemia. J. Surg. Res. 58, 536-540.
19. Morotoki, H., Hisayama, T., Takeuchi, S., Miuano, H., and Kondoh, W. (1992). Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta. Br. J. Pharmacol. 107, 196-201.
20. Oshiro, H., Kobayashi, I., Kim, D., Takenaka, H., Hobson, R. W., II, and Duran, W. N. (1995). L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo. J. Vasc. Surg. 22, 732-741.
21. Plitman, J. D., and Snapper, J. R. (1994). Effects of endotoxin on airway function. In "Endotoxin and the Lungs" (K. L. Brigham, Ed.), pp. 133-152. Dekker, New York.
22. Shibmaoto, T., Yamaguchi, Y., Hayashi, T., Jr., Saeki, Y., Kawamoto, M., and Koyama, S. (1993). PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs. Am. J. Physiol. 264, H1454-1459.
23. Slaaf, D. W., Tangelder, G. J., Renemon, R. S., Jäger, K., and Bollinger, A. (1987). A versatile incident illuminator for intravital microscopy. Int. J. Microcirc. Clin. Exp. 6, 391-397.
24. Uhlig, S., Wollin, L., and Wendel, A. (1994). Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. J. Appl. Physiol. 77, 262-269.
25. Vallance, P., Collier, J., and Moncada, S. (1989). Nitric oxide synthesized from L-arginine mediates endothelium dependent dilation in human veins in vivo. Cardiovasc. Res. 23, 1053-1057.
26. Wagner, E. M., and Mitzner, W. A. (1990). Bronchial circulatory reversal of methacholine-induced airway constriction. J. Appl. Physiol. 69, 1220-1224.
27. Wanner, A., and Long, W. M. (1992). Airways, asthma, bronchitis, and emphysema. In "The Bronchial Circulation" (J. Butler, Ed.), pp. 493-517. Dekker, New York.